-Patricia Polacino Researcher Activity Profile

Research Author Detailed Information 

Patricia Polacino Publication Rate By Year

Patricia Polacino has published 1 paper(s) in 2006, 4 paper(s) in 2007, 2 paper(s) in 2008, for a total of 7 research publications in total.

Patricia P Polacino Author Information

LAST NAME: polacino

FIRST NAME: Patricia

INITIALS: p

AFFILIATION:

Papers

Patricia Polacino's Publication Record

1. Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3. Year Published: 2006
Departments of Pathobiology, National Primate Research Center, University of Washington, Seattle, Washington 98195, USA.
2. Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. Year Published: 2007
Washington National Primate Research Center, University of Washington, Seattle, WA, USA.
3. Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges. Year Published: 2007
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
4. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. Year Published: 2007
HIV Drug Resistance Program, National Cancer Institute, Building 535, Room 123, Frederick, MD 21702, USA.
5. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. Year Published: 2007
HIV Drug Resistance Program, National Cancer Institute, Building 535, Room 123, Frederick, MD 21702, USA.
6. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. Year Published: 2008
Washington National Primate Center, University of Washington, 3000 Western Ave., Seattle, WA 98121, USA.
7. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. Year Published: 2008
Washington National Primate Center, University of Washington, 3000 Western Ave., Seattle, WA 98121, USA.